The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspective
- PMID: 33381908
- DOI: 10.1002/pbc.28871
The Best Pharmaceuticals for Children Act and Pediatric Research Equity Act reach the age of majority-An oncology perspective
Abstract
The scarcity of adequate pediatric drug labeling information has long been problematic in the pediatric population, which may place children at risk for adverse drug effects. The ontogeny of infants, children, and adolescents over the course of the first two decades of life pose complex pharmacokinetic, dosing, administration, effectiveness, and toxicity-related questions that require specific investigation. Here, we review the history that led to the passage of the Best Pharmaceuticals for Children Act (BPCA) and Pediatric Research Equity Act (PREA), and provide commentary on issues relevant to pediatric oncology now and in the future.
Keywords: Best Pharmaceuticals for Children Act; PediatricResearch Equity Act; drug labeling; research.
© 2020 Wiley Periodicals LLC.
Similar articles
-
Safety monitoring of drugs granted exclusivity under the Best Pharmaceuticals for Children Act: what the FDA has learned.Clin Pharmacol Ther. 2007 Aug;82(2):133-4. doi: 10.1038/sj.clpt.6100285. Clin Pharmacol Ther. 2007. PMID: 17632537
-
Review of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act: What can the obstetric community learn from the pediatric experience?Semin Perinatol. 2015 Nov;39(7):530-1. doi: 10.1053/j.semperi.2015.08.006. Epub 2015 Oct 9. Semin Perinatol. 2015. PMID: 26455383 Free PMC article. Review.
-
Assessment of the Impact of Mandated Postmarketing Pediatric-Focused Safety Reviews on Safety-Related Regulatory Actions 2013-2019.Clin Pharmacol Ther. 2023 Jun;113(6):1368-1377. doi: 10.1002/cpt.2900. Epub 2023 Apr 28. Clin Pharmacol Ther. 2023. PMID: 37021630
-
Dermatology Drugs for Children-U.S. Food and Drug Administration Perspective.Dermatol Clin. 2022 Jul;40(3):289-296. doi: 10.1016/j.det.2022.02.004. Epub 2022 Jun 1. Dermatol Clin. 2022. PMID: 35750412 Review.
-
Modeling and simulation in pediatric drug therapy: Application of pharmacometrics to define the right dose for children.Clin Pharmacol Ther. 2015 Sep;98(3):298-308. doi: 10.1002/cpt.169. Epub 2015 Jul 20. Clin Pharmacol Ther. 2015. PMID: 26073179 Review.
Cited by
-
Clinical Trials for Special Populations: Children, Older Adults, and Rare Diseases.Mayo Clin Proc. 2024 Feb;99(2):318-335. doi: 10.1016/j.mayocp.2023.03.003. Mayo Clin Proc. 2024. PMID: 38309939 Free PMC article. Review.
-
Drug labeling changes and pediatric hematology/oncology prescribing: Measuring the impact of U.S. legislation.Clin Trials. 2021 Dec;18(6):732-740. doi: 10.1177/17407745211030683. Epub 2021 Jul 16. Clin Trials. 2021. PMID: 34269090 Free PMC article.
-
Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children.Pharmaceutics. 2025 May 17;17(5):658. doi: 10.3390/pharmaceutics17050658. Pharmaceutics. 2025. PMID: 40430948 Free PMC article.
-
Nanomedicine Therapies for Pediatric Diseases.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1996. doi: 10.1002/wnan.1996. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 39420230 Free PMC article. Review.
References
REFERENCES
-
- Deaths due to elixir of sulfanilamide-Massengill: report of the Secretary of Agriculture submitted to House Resolution 352 of November 19, 1937 and Senate Resolution of November 16, 1937. JAMA. 1937;109:1985-1988
-
- Taussig HB. A study of the German outbreak of phocomelia. JAMA. 1962;198:1106-1114.
-
- Lenz W. A study of the German outbreak of phocomelia. Lancet. 1962;2:1332.
-
- Burns LE, Hodgman JE, Cass AB. Fatal circulatory collapse in premature infants receiving chloramphenicol. N Engl J Med. 1959;261:1318-1321.
-
- Sutherland JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child. 1959;97:761.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical